Literature DB >> 26980765

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).

Kenji Tsuchihashi1, Shogo Okazaki2, Mitsuyo Ohmura3, Miyuki Ishikawa2, Oltea Sampetrean2, Nobuyuki Onishi2, Hiroaki Wakimoto4, Momoko Yoshikawa2, Ryo Seishima2, Yoshimi Iwasaki2, Takayuki Morikawa5, Shinya Abe6, Ayumi Takao6, Misato Shimizu6, Takashi Masuko6, Motoo Nagane7, Frank B Furnari8, Tetsu Akiyama9, Makoto Suematsu3, Eishi Baba10, Koichi Akashi10, Hideyuki Saya2, Osamu Nagano11.   

Abstract

Extracellular free amino acids contribute to the interaction between a tumor and its microenvironment through effects on cellular metabolism and malignant behavior. System xc(-) is composed of xCT and CD98hc subunits and functions as a plasma membrane antiporter for the uptake of extracellular cystine in exchange for intracellular glutamate. Here, we show that the EGFR interacts with xCT and thereby promotes its cell surface expression and function in human glioma cells. EGFR-expressing glioma cells manifested both enhanced antioxidant capacity as a result of increased cystine uptake, as well as increased glutamate, which promotes matrix invasion. Imaging mass spectrometry also revealed that brain tumors formed in mice by human glioma cells stably overexpressing EGFR contained higher levels of reduced glutathione compared with those formed by parental cells. Targeted inhibition of xCT suppressed the EGFR-dependent enhancement of antioxidant capacity in glioma cells, as well as tumor growth and invasiveness. Our findings establish a new functional role for EGFR in promoting the malignant potential of glioma cells through interaction with xCT at the cell surface. Cancer Res; 76(10); 2954-63. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26980765      PMCID: PMC4873328          DOI: 10.1158/0008-5472.CAN-15-2121

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  What is the clinical value of cancer stem cell markers in gliomas?

Authors:  Rikke Hedegaard Dahlrot; Simon Kjær Hermansen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

2.  Molecular imaging of hydrogen peroxide produced for cell signaling.

Authors:  Evan W Miller; Orapim Tulyathan; Orapim Tulyanthan; Ehud Y Isacoff; Christopher J Chang
Journal:  Nat Chem Biol       Date:  2007-04-01       Impact factor: 15.040

3.  Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity.

Authors:  Candice E Paulsen; Thu H Truong; Francisco J Garcia; Arne Homann; Vinayak Gupta; Stephen E Leonard; Kate S Carroll
Journal:  Nat Chem Biol       Date:  2011-12-11       Impact factor: 15.040

4.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

Review 5.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

6.  The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.

Authors:  R Koyama-Nasu; R Haruta; Y Nasu-Nishimura; K Taniue; Y Katou; K Shirahige; T Todo; Y Ino; A Mukasa; N Saito; M Matsui; R Takahashi; A Hoshino-Okubo; H Sugano; E Manabe; K Funato; T Akiyama
Journal:  Oncogene       Date:  2013-05-20       Impact factor: 9.867

7.  Autocrine glutamate signaling promotes glioma cell invasion.

Authors:  Susan A Lyons; W Joon Chung; Amy K Weaver; Toyin Ogunrinu; Harald Sontheimer
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

8.  CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

Authors:  Aymee Perez; David M Neskey; Judy Wen; Lutecia Pereira; Erika P Reategui; W Jarrard Goodwin; Kermit L Carraway; Elizabeth J Franzmann
Journal:  Oral Oncol       Date:  2012-12-20       Impact factor: 5.337

9.  EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

Authors:  Qi-Wen Fan; Christine K Cheng; W Clay Gustafson; Elizabeth Charron; Petra Zipper; Robyn A Wong; Justin Chen; Jasmine Lau; Christiane Knobbe-Thomsen; Michael Weller; Natalia Jura; Guido Reifenberger; Kevan M Shokat; William A Weiss
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

Review 10.  Tumor macroenvironment and metabolism.

Authors:  Wael Al-Zoughbi; Wael Al-Zhoughbi; Jianfeng Huang; Ganapathy S Paramasivan; Holger Till; Martin Pichler; Barbara Guertl-Lackner; Gerald Hoefler
Journal:  Semin Oncol       Date:  2014-03-01       Impact factor: 4.929

View more
  36 in total

Review 1.  Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.

Authors:  Ji Zhang; Natalya N Pavlova; Craig B Thompson
Journal:  EMBO J       Date:  2017-04-18       Impact factor: 11.598

2.  Prometheus revisited.

Authors:  Kai-Yuan Chen; Xiling Shen; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

Review 3.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

4.  Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.

Authors:  Takeo Goji; Kazuhiko Takahara; Manabu Negishi; Hironori Katoh
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

5.  mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.

Authors:  Yuchao Gu; Claudio P Albuquerque; Daniel Braas; Wei Zhang; Genaro R Villa; Junfeng Bi; Shiro Ikegami; Kenta Masui; Beatrice Gini; Huijun Yang; Timothy C Gahman; Andrew K Shiau; Timothy F Cloughesy; Heather R Christofk; Huilin Zhou; Kun-Liang Guan; Paul S Mischel
Journal:  Mol Cell       Date:  2017-06-22       Impact factor: 17.970

6.  Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy.

Authors:  Ilya V Ulasov; Haidn Foster; Mike Butters; Jae-Geun Yoon; Tomoko Ozawa; Theodore Nicolaides; Xavier Figueroa; Parvinder Hothi; Michael Prados; John Butters; Charles Cobbs
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

Review 7.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

8.  High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).

Authors:  Itsuki Yamaguchi; Shige H Yoshimura; Hironori Katoh
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

Review 9.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Combating malignant astrocytes: Strategies mitigating tumor invasion.

Authors:  Robyn A Umans; Harald Sontheimer
Journal:  Neurosci Res       Date:  2017-10-18       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.